These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 20067329)

  • 1. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.
    Bachert C; Maurer M
    Clin Drug Investig; 2010; 30(2):109-22. PubMed ID: 20067329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients.
    Augustin M; Ehrle S
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):292-9. PubMed ID: 19438819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of desloratadine for the management of allergic disease.
    Berger WE
    Drug Saf; 2005; 28(12):1101-18. PubMed ID: 16329713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
    DuBuske L
    Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
    Ortonne JP; Grob JJ; Auquier P; Dreyfus I
    Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of desloratadine syrup in children.
    Bloom M; Staudinger H; Herron J
    Curr Med Res Opin; 2004 Dec; 20(12):1959-65. PubMed ID: 15701213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
    Raphael GD; Angello JT; Wu MM; Druce HM
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
    Grubbe RE; Lumry WR; Anolik R
    J Investig Allergol Clin Immunol; 2009; 19(2):117-24. PubMed ID: 19476015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
    Devillier P; Roche N; Faisy C
    Clin Pharmacokinet; 2008; 47(4):217-30. PubMed ID: 18336052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.
    Crampton HJ
    Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Ring J; Hein R; Gauger A; Bronsky E; Miller B
    Int J Dermatol; 2001 Jan; 40(1):72-6. PubMed ID: 11277962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
    Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY
    Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
    Glass DJ; Harper AS
    BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trial.
    Keith PK; Luciuk G
    Clin Ther; 2007 Mar; 29(3):419-26. PubMed ID: 17577463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult and paediatric poor metabolisers of desloratadine: an assessment of pharmacokinetics and safety.
    Prenner B; Kim K; Gupta S; Khalilieh S; Kantesaria B; Manitpisitkul P; Lorber R; Wang Z; Lutsky B
    Expert Opin Drug Saf; 2006 Mar; 5(2):211-23. PubMed ID: 16503743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multicenter study of the effectiveness and tolerability of desloratadine in seasonal allergic rhinitis].
    Farkas H
    Orv Hetil; 2003 May; 144(21):1021-4. PubMed ID: 12847854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
    Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
    Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of desloratadine for the treatment of allergic rhinitis, chronic idiopathic urticaria and allergic inflammatory disorders.
    DuBuske LM
    Expert Opin Pharmacother; 2005 Nov; 6(14):2511-23. PubMed ID: 16259582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.